Yes Rowdy................same situation with Resmed and may others........RMD was recommended as a buy/strong buy by every broker report I've seen on it...........all the way from $12 to $4.40 just recently. Just illustrates that most research houses should get a technical analyst who knows their stuff and that their methods (DCF etc........) often leave a lot to be desired.
Takes another hammering, page-4
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$301.70 |
Change
1.830(0.61%) |
Mkt cap ! $145.1B | |||
| Open | High | Low | Value | Volume |
| $301.73 | $301.85 | $300.32 | $15.60M | 51.76K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 30 | $301.68 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $301.72 | 19 | 4 |
View Market Depth
| Last trade - 10.36am 12/09/2024 (20 minute delay) ? |
| CSL (ASX) Chart |